Literature DB >> 19689610

Migraine and genetic and acquired vasculopathies.

A H Stam1, J Haan, A M J M van den Maagdenberg, M D Ferrari, G M Terwindt.   

Abstract

It is remarkable that migraine is a prominent part of the phenotype of several genetic vasculopathies, including cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL), retinal vasculopathy with cerebral leukodystrophy (RVCL) and hereditary infantile hemiparessis, retinal arteriolar tortuosity and leukoencephalopahty (HIHRATL). The mechanisms by which these genetic vasculopathies give rise to migraine are still unclear. Common genetic susceptibility, increased susceptibility to cortical spreading depression (CSD) and vascular endothelial dysfunction are among the possible explanations. The relation between migraine and acquired vasculopathies such as ischaemic stroke and coronary heart disease has long been established, further supporting a role of the (cerebral) blood vessels in migraine. This review focuses on genetic and acquired vasculopathies associated with migraine. We speculate how genetic and acquired vascular mechanisms might be involved in migraine.

Entities:  

Mesh:

Year:  2009        PMID: 19689610     DOI: 10.1111/j.1468-2982.2009.01940.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  24 in total

1.  Migraine mutations increase stroke vulnerability by facilitating ischemic depolarizations.

Authors:  Katharina Eikermann-Haerter; Jeong Hyun Lee; Izumi Yuzawa; Christina H Liu; Zhipeng Zhou; Hwa Kyoung Shin; Yi Zheng; Tao Qin; Tobias Kurth; Christian Waeber; Michel D Ferrari; Arn M J M van den Maagdenberg; Michael A Moskowitz; Cenk Ayata
Journal:  Circulation       Date:  2011-12-05       Impact factor: 29.690

2.  The Arg-62 residues of the TREX1 exonuclease act across the dimer interface contributing to catalysis in the opposing protomers.

Authors:  Jason M Fye; Stephanie R Coffin; Clinton D Orebaugh; Thomas Hollis; Fred W Perrino
Journal:  J Biol Chem       Date:  2014-03-09       Impact factor: 5.157

Review 3.  An update on the blood vessel in migraine.

Authors:  K C Brennan; Andrew Charles
Journal:  Curr Opin Neurol       Date:  2010-06       Impact factor: 5.710

Review 4.  Pathophysiology of the neurovascular unit: disease cause or consequence?

Authors:  Danica B Stanimirovic; Alon Friedman
Journal:  J Cereb Blood Flow Metab       Date:  2012-03-07       Impact factor: 6.200

Review 5.  Migraine and neurogenetic disorders.

Authors:  Swati Sathe
Journal:  Curr Pain Headache Rep       Date:  2013-09

Review 6.  Development of anti-migraine therapeutics using the capsaicin-induced dermal blood flow model.

Authors:  Linde Buntinx; Steve Vermeersch; Jan de Hoon
Journal:  Br J Clin Pharmacol       Date:  2015-10-06       Impact factor: 4.335

Review 7.  Verisimilitude (or "truthlikeness") as an alternative to pro and cons: migraine and cluster headache mechanisms.

Authors:  Peer Carsten Tfelt-Hansen
Journal:  J Headache Pain       Date:  2010-07-07       Impact factor: 7.277

Review 8.  The Role of Endothelin in the Pathophysiology of Migraine-a Systematic Review.

Authors:  Afrim Iljazi; Cenk Ayata; Messoud Ashina; Anders Hougaard
Journal:  Curr Pain Headache Rep       Date:  2018-03-19

9.  Familial and sporadic hemiplegic migraine: diagnosis and treatment.

Authors:  Nadine Pelzer; Anine H Stam; Joost Haan; Michel D Ferrari; Gisela M Terwindt
Journal:  Curr Treat Options Neurol       Date:  2013-02       Impact factor: 3.598

10.  Simvastatin and vitamin D for migraine prevention: A randomized, controlled trial.

Authors:  Catherine Buettner; Rony-Reuven Nir; Suzanne M Bertisch; Carolyn Bernstein; Aaron Schain; Murray A Mittleman; Rami Burstein
Journal:  Ann Neurol       Date:  2015-11-13       Impact factor: 10.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.